跳至主要内容
临床试验/NCT05734391
NCT05734391Enrolling By Invitation不适用

Surveillance of Healthcare-associated Infections & Antimicrobial Resistance

University of Pennsylvania2 个研究点 分布在 2 个国家目标入组 1,500 人开始时间: 2022年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
1,500
试验地点
2
主要终点
Expertise

研究概览

简要总结

The aims of this project, called "Surveillance of Healthcare-associated infections & Antimicrobial Resistance", or "SHARE", are to 1) enhance laboratory capacity to detect emerging AMR patterns; 2) strengthen hospital epidemiology programs to use data to prevent, detect, and contain emerging AMR threats; 3) deploy study teams to answer critical public health surveillance questions, and 4) to build a national network of infection prevention and control (IPC) resources to prevent, detect, and contain emerging infectious disease threats

详细描述

The World Health Organization (WHO) has declared antimicrobial resistance (AMR) one of the top 10 global public health threats facing humanity. AMR burden is higher in low-and-middle-income countries (LMICs) where, in recent decades, incidence and mortality from healthcare-associated infections (HAI) due to multidrug resistant organisms (MDRO) have dramatically increased. For example, neonatal sepsis is the third most common cause of neonatal deaths and multidrug-resistant Gram-negative bacteria are now the leading cause of sepsis among hospitalized neonates in south Asia and sub-Saharan Africa, including Botswana.1,2 One in three newborns with an MDRO bloodstream infection will die.3 In 2021, to respond to the global threat of AMR, U.S. Centers for Disease Control & Prevention (CDC) announced the launch of a global "network of networks" to tackle the problem of AMR and healthcare-associated infections (HAIs). The network, called "Global Antimicrobial Resistance Laboratory and Response Network", solicited funding applications; in December of 2021, Botswana was announced as recipient of a 5-year cooperative agreement following the successful application for funding for a comprehensive AMR surveillance project. The project was developed by investigators from Botswana-UPenn Partnership (BUP) in collaboration with Botswana's Ministry of Health & Wellness (MOHW) and the University of Botswana (UB).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • hospital inpatient admission to participating wards.

排除标准

  • diagnosis of a bleeding disorder
  • platelet counts of <50,000
  • diagnosis of coagulopathy
  • presence of active bleeding
  • inability to have a nares swab collected due to some other condition where nasal swabbing would be contraindicated
  • inability to have a rectal swab collected due to some other condition where rectal swabbing would be contraindicated

结局指标

主要结局

Expertise

时间窗: 12 months

Ultimately, the goal of the SHARE project is to assemble the expertise and infrastructure needed to build a resilient HAI/AMR surveillance system fully-incorporated into MOHW's surveillance activities. The project aims to build capacity, both material and knowledge, in existing laboratory and IPC teams to face the dynamic challenges posed by HAIs and AMR

次要结局

  • Feasibility and Surveillance(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ebbing Lautenbach

Corrado Cancedda

University of Pennsylvania

研究点 (2)

Loading locations...

相似试验

Surveillance of Healthcare-associated Infections &... | 临床试验